Concussion-sensing device receives FDA market approval

William Doss | September 30, 2016 | Radiology Business | Policy & Regulations

A wearable device that senses electronic brain activity and diagnoses brain damage received clearance from the U.S. Food and Drug Administration, allowing BrainScope to market the product commercially.

The Maryland-based company is backed by AOL founder Steve Case and receives funding from entities as varied as the Department of Defense and the National Football League.

The device has electrodes to measure brain activity and sends information to a specially configured Android phone. This is Brainscope's third device to gain FDA approval. (The previous two were for non-commercial use.)

Follow the link below to read more about BrainScope at the Star Tribune:

FDA clears wearable device to measure concussions

William Doss

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Related Content